Adalimumab

Details

Files

Generic Name:

Adalimumab

Project Status:

Complete

Therapeutic Area:

Arthritis, Psoriatic

Manufacturer:

Abbott Laboratories Limited

Brand Name:

Humira

Project Line:

Reimbursement Review

Project Number:

SR0066-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Resubmission

Indications:

Arthritis, Psoriatic

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

November 29, 2006

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : June 21, 2006